Hosted by the HTAi Medical Devices Interest Group, this webinar explores why stronger and more transparent clinical evidence is needed when dealing with high risk medical devices, how a four-stage framework of clinical investigations can improve device evaluation, and why randomized controlled trials, registry-based studies, and post-market follow-up are crucial for ensuring safety and efficacy.
Lead Speaker is Prof. Alan Fraser, Consultant Cardiologist at the University Hospital of Wales; Visiting Professor in Cardiovascular Imaging and Dynamics at the University of Leuven; and Emeritus Professor of Cardiology at the Wales Heart Research Institute, Cardiff University. The webinar is moderated by Richard Charter, Co-Chair of the HTAi Medical Devices Interest Group.
Watch the clip below and then follow the button to view the entire webinar on-demand.